Pulsed Electro Magnetic Fields (PEMF) in Depression (PEMF)
Primary Purpose
Depression, Unipolar
Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Treatment with PEMF equipment
Sponsored by

About this trial
This is an interventional treatment trial for Depression, Unipolar focused on measuring Depression, unipolar, Treatment resistant, PEMF
Eligibility Criteria
Inclusion Criteria:
- Treatment resistant depression is defined as treatment with at least two antidepressants from different classes in an optimal dose and with sufficient duration (at least 8 weeks).
- A score on HamD17 above 17.
- Antidepressant medication must not have been changed 4 weeks before inclusion.
Exclusion Criteria:
A Ham-D17 item 3 at 2 or more (suicidal risk increased) A moderate manic condition (MAS-M above 14) The participant must not be under some sort of restrictions Pregnancy Severe personality disorders Psychotic mental disorders Brain diseases
Sites / Locations
- Department of Psychiatry, Psychiatry in the Region of Southern Denmark
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
PEMF treatment
Arm Description
No sham group (placebo) was chosen. Treatment consisted of one active group in a multicenter study.
Outcomes
Primary Outcome Measures
Change in the Hamilton Depression Scale (HAM-D17)
HamD17 scale
Secondary Outcome Measures
Life Quality
WHO-5 scale
Side effects
Prise scale
Response and remission
HamD17 scale
Full Information
NCT ID
NCT03556735
First Posted
June 1, 2018
Last Updated
April 17, 2019
Sponsor
University of Southern Denmark
Collaborators
Aarhus University Hospital, Rigshospitalet, Denmark, Aalborg University Hospital, Glostrup University Hospital, Copenhagen, Mental Health Centre Copenhagen, Odense University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03556735
Brief Title
Pulsed Electro Magnetic Fields (PEMF) in Depression
Acronym
PEMF
Official Title
Evaluation Plan for Pulsed Electro Magnetic Fields (PEMF) in a Cohort Study for Patients With Unipolar Depression, Refractory to Antidepressant Drugs. A DUAG (Danish University Antidepressant Group) Study Over 8 Weeks.
Study Type
Interventional
2. Study Status
Record Verification Date
June 2018
Overall Recruitment Status
Completed
Study Start Date
September 2016 (Actual)
Primary Completion Date
November 2017 (Actual)
Study Completion Date
December 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Southern Denmark
Collaborators
Aarhus University Hospital, Rigshospitalet, Denmark, Aalborg University Hospital, Glostrup University Hospital, Copenhagen, Mental Health Centre Copenhagen, Odense University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
PEMF (Pulsed Electro Magnetic Fields) therapy has been used to stimulate bone repair in non-union since the 1970s. This is an accepted use, which has been approved by the Food and Drug Administration in the US. The mode of action of PEMF is based on creating small electrical fields in tissue and thereby promoting healing. Besides it has been shown that PEMF enhance regeneration of nerve fibers exposed to a lesion For treatment of depression the PEMF equipment, which are provided by the company Re5 A/S, consists of a 220 V impulse generator that creates electrical impulses and an applicator which consists of an electrical cable connected to a helmet on which there are 7 electrical coils on the inside. In comparison with the rTMS (Transcranial Magnetic Stimulation) equipment, which uses stimuli approaching neuronal firing level, the PEMF fields in human is very much lower.
Detailed Description
Applied to cells PEMF have a stimulatory effect on intracellular tyrosine kinase activity, especially the Src family. The Src family upregulate NMDAR (N-methyl-D-aspartate) subtype of glutamate receptor thereby gating the production of NMDAR-dependent synaptic potentiation that are vital for processes that underlie physiological and pathological plasticity in the brain. Dysregulation of fibroblast growth factor receptors in frontal cortical regions of the brain seem to be associated with depression. The fibroblast growth factors are highly dependent on the activity of the Src family.
For treatment of depression the PEMF equipment, which are provided by the company Re5 A/S, consists of a 220 V impulse generator that creates electrical impulses and an applicator which consists of an electrical cable connected to a helmet on which there are 7 electrical coils on the inside. In comparison with the rTMS equipment, which uses stimuli approaching neuronal firing level, the PEMF fields in human are very much lower.
PEMF treatment involves placing the treatment helmet on the head and connecting it to a power source (220 V), which leads to induction of a pulsating magnetic field. The treatment was given for 30 min once or twice daily for 8 weeks. Participants are awake during these treatments and sit in a chair where they can read or eat. Pilot data demonstrates that the treatment can give mild transient nausea. No other side effects have been observed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression, Unipolar
Keywords
Depression, unipolar, Treatment resistant, PEMF
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
59 (Actual)
8. Arms, Groups, and Interventions
Arm Title
PEMF treatment
Arm Type
Other
Arm Description
No sham group (placebo) was chosen. Treatment consisted of one active group in a multicenter study.
Intervention Type
Device
Intervention Name(s)
Treatment with PEMF equipment
Intervention Description
Treatment with PEMF in 8 weeks
Primary Outcome Measure Information:
Title
Change in the Hamilton Depression Scale (HAM-D17)
Description
HamD17 scale
Time Frame
8 weeks
Secondary Outcome Measure Information:
Title
Life Quality
Description
WHO-5 scale
Time Frame
8 weeks
Title
Side effects
Description
Prise scale
Time Frame
8 weeks
Title
Response and remission
Description
HamD17 scale
Time Frame
8 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Treatment resistant depression is defined as treatment with at least two antidepressants from different classes in an optimal dose and with sufficient duration (at least 8 weeks).
A score on HamD17 above 17.
Antidepressant medication must not have been changed 4 weeks before inclusion.
Exclusion Criteria:
A Ham-D17 item 3 at 2 or more (suicidal risk increased) A moderate manic condition (MAS-M above 14) The participant must not be under some sort of restrictions Pregnancy Severe personality disorders Psychotic mental disorders Brain diseases
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Erik R. Larsen, MD
Organizational Affiliation
Institute of Clinical Research, Research Unit of Psychiatry, University of Southern Denmark
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Psychiatry, Psychiatry in the Region of Southern Denmark
City
Odense
State/Province
Region Of Southern Denmark
ZIP/Postal Code
5000
Country
Denmark
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Publication in Peer-Reviewed Journals Participation in Congresses
IPD Sharing Time Frame
Planned to be published in 2018
Learn more about this trial
Pulsed Electro Magnetic Fields (PEMF) in Depression
We'll reach out to this number within 24 hrs